• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外产生的爱泼斯坦-巴尔病毒特异性细胞毒性T淋巴细胞的细胞溶解机制及T细胞受体Vβ使用情况

Cytolytic mechanisms and T-cell receptor Vbeta usage by ex vivo generated Epstein-Barr virus-specific cytotoxic T lymphocytes.

作者信息

Vanhoutte Victoria J, McAulay Karen A, McCarrell Erin, Turner Marc, Crawford Dorothy H, Haque Tanzina

机构信息

Clinical and Molecular Virology, University of Edinburgh, Summerhall, Edinburgh, UK.

出版信息

Immunology. 2009 Aug;127(4):577-86. doi: 10.1111/j.1365-2567.2008.03035.x.

DOI:10.1111/j.1365-2567.2008.03035.x
PMID:19604308
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2729535/
Abstract

Ex-vivo-generated Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes (CTL) have been used for cellular adoptive immunotherapy of EBV-associated lymphomas. Here we investigated the phenotypes, cytolytic mechanisms, polyfunctionality and T-cell receptor (TCR) usage in growing and established CTL, generated by weekly stimulation with an EBV-transformed autologous lymphoblastoid cell line (LCL). Our results showed that phenotypically mature CTL developed within the first 4 weeks of culture, with an increase in CD45RO and CD69, and a decrease in CD45RA, CD62L, CD27 and CD28 expression. Spectratyping analysis of the variable beta-chain of the TCR revealed that TCR repertoire remained diverse during the course of culture. Cytotoxicity of CTL was significantly inhibited by concanamycin A (P < 0.0001) and ethylene glycol-bis tetraacetic acid (P < 0.0001), indicating that a calcium and perforin-mediated exocytosis pathway with the release of granzyme B was the principal cytotoxic mechanism. The CTL mainly produced interferon-gamma (IFN-gamma) or tumour necrosis factor-alpha (TNF-alpha) upon restimulation with autologous LCL, although there were some polyfunctional cells producing IFN-gamma and TNF-alpha. Granzyme B, perforin and Fas ligand were detected in CD8(+) and CD4(+) cells in all CTL; however, a greater proportion of CD8(+) than CD4(+) T cells expressed granzyme B (P < 0.0001) and more granzyme B was detected in CD8(+) T cells than in CD4(+) T cells (P = 0.001). This difference was not observed with Fas ligand or perforin expression. Our results provide insight into the basic characteristics of ex-vivo-generated CTL.

摘要

体外产生的爱泼斯坦-巴尔病毒(EBV)特异性细胞毒性T淋巴细胞(CTL)已被用于EBV相关淋巴瘤的细胞过继性免疫治疗。在此,我们研究了通过每周用EBV转化的自体淋巴母细胞系(LCL)刺激产生的正在生长的和已建立的CTL的表型、细胞溶解机制、多功能性和T细胞受体(TCR)使用情况。我们的结果表明,表型成熟的CTL在培养的前4周内形成,CD45RO和CD69增加,而CD45RA、CD62L、CD27和CD28表达减少。TCR可变β链的谱型分析显示,在培养过程中TCR库保持多样化。抗霉素A(P < 0.0001)和乙二醇双四乙酸(P < 0.0001)可显著抑制CTL的细胞毒性,表明钙和穿孔素介导的伴有颗粒酶B释放的胞吐途径是主要的细胞毒性机制。在用自体LCL再次刺激时,CTL主要产生干扰素-γ(IFN-γ)或肿瘤坏死因子-α(TNF-α),尽管有一些多功能细胞同时产生IFN-γ和TNF-α。在所有CTL的CD8(+)和CD4(+)细胞中均检测到颗粒酶B、穿孔素和Fas配体;然而,表达颗粒酶B的CD8(+) T细胞比例高于CD4(+) T细胞(P < 0.0001),且在CD8(+) T细胞中检测到的颗粒酶B比CD4(+) T细胞中的更多(P = 0.001)。Fas配体或穿孔素表达未观察到这种差异。我们的结果为体外产生的CTL的基本特征提供了见解。

相似文献

1
Cytolytic mechanisms and T-cell receptor Vbeta usage by ex vivo generated Epstein-Barr virus-specific cytotoxic T lymphocytes.体外产生的爱泼斯坦-巴尔病毒特异性细胞毒性T淋巴细胞的细胞溶解机制及T细胞受体Vβ使用情况
Immunology. 2009 Aug;127(4):577-86. doi: 10.1111/j.1365-2567.2008.03035.x.
2
Involvement of CD27/CD70 interactions in antigen-specific cytotoxic T-lymphocyte (CTL) activity by perforin-mediated cytotoxicity.CD27/CD70相互作用通过穿孔素介导的细胞毒性参与抗原特异性细胞毒性T淋巴细胞(CTL)活性。
Clin Exp Immunol. 2002 Dec;130(3):424-30. doi: 10.1046/j.1365-2249.2002.02012.x.
3
Granule exocytosis, and not the fas/fas ligand system, is the main pathway of cytotoxicity mediated by alloantigen-specific CD4(+) as well as CD8(+) cytotoxic T lymphocytes in humans.颗粒胞吐作用而非fas/fas配体系统,是人类同种抗原特异性CD4(+)以及CD8(+)细胞毒性T淋巴细胞介导的细胞毒性的主要途径。
Blood. 2000 Apr 1;95(7):2352-5.
4
Cytokine production and cytolytic mechanism of CD4(+) cytotoxic T lymphocytes in ex vivo expanded therapeutic Epstein-Barr virus-specific T-cell cultures.体外扩增的治疗性爱泼斯坦-巴尔病毒特异性T细胞培养物中CD4(+) 细胞毒性T淋巴细胞的细胞因子产生及细胞溶解机制
Blood. 2002 May 1;99(9):3302-9. doi: 10.1182/blood.v99.9.3302.
5
Functional CD4(+) and CD8(+) T-cell responses induced by autologous mitomycin C treated Epstein-Barr virus transformed lymphoblastoid cell lines.经自体丝裂霉素C处理的爱泼斯坦-巴尔病毒转化淋巴母细胞系诱导的功能性CD4(+)和CD8(+) T细胞反应
Cell Immunol. 2001 Feb 25;208(1):25-33. doi: 10.1006/cimm.2001.1760.
6
Human small intestinal mucosa harbours a small population of cytolytically active CD8+ alphabeta T lymphocytes.人类小肠黏膜中存在一小部分具有细胞溶解活性的CD8+αβ T淋巴细胞。
Immunology. 2002 Aug;106(4):476-85. doi: 10.1046/j.1365-2567.2002.01461.x.
7
Age-associated Epstein-Barr virus-specific T cell responses in seropositive healthy adults.血清阳性健康成年人中与年龄相关的 EBV 特异性 T 细胞反应。
Clin Exp Immunol. 2014 Jul;177(1):320-32. doi: 10.1111/cei.12337.
8
Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand.自体移植物抗宿主病中的细胞溶解效应机制与基因表达:穿孔素和Fas配体的不同作用
Biol Blood Marrow Transplant. 2004 Mar;10(3):156-70. doi: 10.1016/j.bbmt.2003.10.005.
9
Ex vivo priming of naïve T cells into EBV-specific Th1/Tc1 effector cells by mature autologous DC loaded with apoptotic/necrotic LCL.通过负载凋亡/坏死性LCL的成熟自体树突状细胞将初始T细胞体外致敏为EBV特异性Th1/Tc1效应细胞。
Am J Transplant. 2003 Nov;3(11):1369-77. doi: 10.1046/j.1600-6135.2003.00252.x.
10
CD4(+) Epstein-Barr virus-specific cytotoxic T-lymphocytes from human umbilical cord blood.来自人脐带血的CD4(+) 爱泼斯坦-巴尔病毒特异性细胞毒性T淋巴细胞
Cell Immunol. 1999 Aug 1;195(2):81-8. doi: 10.1006/cimm.1999.1514.

引用本文的文献

1
Peripheral EBV antigen-specific T cell is dysfunctional in Epstein-Barr virus positive diffuse large B-cell lymphoma.外周血EBV抗原特异性T细胞在爱泼斯坦-巴尔病毒阳性弥漫性大B细胞淋巴瘤中功能失调。
BMC Cancer. 2025 Aug 15;25(1):1318. doi: 10.1186/s12885-025-14723-7.
2
Loss of T-Cell Multifunctionality and TCR-Vβ Repertoire Against Epstein-Barr Virus Is Associated With Worse Prognosis and Clinical Parameters in HIV Patients.T 细胞多功能性和针对 EBV 的 TCR-Vβ repertoire 的丧失与 HIV 患者的预后和临床参数较差相关。
Front Immunol. 2018 Oct 4;9:2291. doi: 10.3389/fimmu.2018.02291. eCollection 2018.
3
Assessment of T-cell receptor repertoire and clonal expansion in peripheral T-cell lymphoma using RNA-seq data.利用 RNA-seq 数据评估外周 T 细胞淋巴瘤中的 T 细胞受体库和克隆扩增。
Sci Rep. 2017 Sep 12;7(1):11301. doi: 10.1038/s41598-017-11310-0.
4
Epstein-Barr virus-specific CD8(+) T lymphocytes from diffuse large B cell lymphoma patients are functionally impaired.弥漫性大B细胞淋巴瘤患者的爱泼斯坦-巴尔病毒特异性CD8(+) T淋巴细胞功能受损。
Clin Exp Immunol. 2015 Nov;182(2):173-83. doi: 10.1111/cei.12682. Epub 2015 Sep 11.
5
Age-associated Epstein-Barr virus-specific T cell responses in seropositive healthy adults.血清阳性健康成年人中与年龄相关的 EBV 特异性 T 细胞反应。
Clin Exp Immunol. 2014 Jul;177(1):320-32. doi: 10.1111/cei.12337.
6
Immunotherapy for EBV-associated malignancies.EBV 相关恶性肿瘤的免疫治疗。
Int J Hematol. 2011 Mar;93(3):281-293. doi: 10.1007/s12185-011-0782-2. Epub 2011 Feb 19.
7
Impact of γ-chain cytokines on EBV-specific T cell cultures.γ 链细胞因子对 EBV 特异性 T 细胞培养的影响。
J Transl Med. 2010 Nov 22;8:121. doi: 10.1186/1479-5876-8-121.

本文引用的文献

1
T-cell quality in memory and protection: implications for vaccine design.记忆与保护中的T细胞质量:对疫苗设计的启示
Nat Rev Immunol. 2008 Apr;8(4):247-58. doi: 10.1038/nri2274. Epub 2008 Mar 7.
2
Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial.异基因细胞毒性T细胞疗法治疗EBV阳性移植后淋巴细胞增殖性疾病:一项2期多中心临床试验的结果
Blood. 2007 Aug 15;110(4):1123-31. doi: 10.1182/blood-2006-12-063008. Epub 2007 Apr 27.
3
CD4+ T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines.CD4 + T细胞对爱泼斯坦-巴尔病毒(EBV)潜伏周期抗原的反应以及对EBV转化的淋巴母细胞系的识别。
J Virol. 2005 Apr;79(8):4896-907. doi: 10.1128/JVI.79.8.4896-4907.2005.
4
Helping the CD8(+) T-cell response.促进CD8(+) T细胞应答。
Nat Rev Immunol. 2004 Aug;4(8):595-602. doi: 10.1038/nri1413.
5
Establishment and characterization of a bank of cytotoxic T lymphocytes for immunotherapy of epstein-barr virus-associated diseases.用于爱泼斯坦-巴尔病毒相关疾病免疫治疗的细胞毒性T淋巴细胞库的建立与鉴定
J Immunother. 2004 Jul-Aug;27(4):309-16. doi: 10.1097/00002371-200407000-00007.
6
Human CD62L- memory T cells are less responsive to alloantigen stimulation than CD62L+ naive T cells: potential for adoptive immunotherapy and allodepletion.人CD62L记忆性T细胞比CD62L+初始T细胞对同种异体抗原刺激的反应性更低:过继性免疫治疗和去淋巴细胞的潜力。
Blood. 2004 Oct 15;104(8):2403-9. doi: 10.1182/blood-2003-12-4431. Epub 2004 Jul 1.
7
Epstein-Barr virus-specific cytotoxic T-lymphocytes for adoptive immunotherapy of post-transplant lymphoproliferative disease.用于移植后淋巴细胞增生性疾病过继性免疫治疗的爱泼斯坦-巴尔病毒特异性细胞毒性T淋巴细胞
Blood Rev. 2004 Sep;18(3):193-209. doi: 10.1016/j.blre.2003.12.002.
8
Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from posttransplant lymphoma after adoptive immunotherapy.潜伏性T淋巴细胞对爱泼斯坦-巴尔病毒反应的重建与过继性免疫治疗后移植后淋巴瘤的长期缓解相一致。
Transplantation. 2003 May 15;75(9):1556-60. doi: 10.1097/01.TP.0000058745.02123.6F.
9
Epstein-Barr virus-recent advances.爱泼斯坦-巴尔病毒——最新进展
Lancet Infect Dis. 2003 Mar;3(3):131-40. doi: 10.1016/s1473-3099(03)00543-7.
10
Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells.采用部分人类白细胞抗原匹配的异基因细胞毒性T细胞治疗爱泼斯坦-巴尔病毒阳性移植后淋巴细胞增生性疾病。
Lancet. 2002 Aug 10;360(9331):436-42. doi: 10.1016/S0140-6736(02)09672-1.